Active ingredientDexlansoprazoleCat. No. P-D073-001CAS 138530-94-6Family · Pharmaceutical analytical standards
Dexlansoprazole
A proton pump inhibitor that reduces acid production in the stomach: it is the R-enantiomer of lansoprazole, approved in the United States in 2009 for erosive oesophagitis and heartburn from gastro-oesophageal reflux disease. This family brings together the active ingredient and other impurities.
Did you know?The capsules contain two kinds of granules with coatings that dissolve at different pH: the drug is released in two waves, with a first blood peak after about one hour and a second about four hours later.
Go to the active ingredient →Active ingredientDexlansoprazoleCat. No. P-D073-001CAS 138530-94-6
Active ingredientDexlansoprazole TrihydrateCat. No. P-D073-002CAS 313640-86-7
ImpurityDexlansoprazole Impurity 1Cat. No. P-D073-003
ImpurityDexlansoprazole Nitro SulfoxideCat. No. P-D073-004CAS 853950-77-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.